Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-30 Purchase |
2023-02-01 4:50 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) |
View |
| 2023-01-30 Purchase |
2023-02-01 4:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) |
View |
| 2023-01-30 Purchase |
2023-02-01 4:29 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) |
View |
| 2023-01-30 Purchase |
2023-02-01 4:26 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
184,272 | $4.9986 | $921,110 | 21,981,782 (Indirect Direct) |
View |
| 2023-01-23 Purchase |
2023-01-25 4:38 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) |
View |
| 2023-01-23 Purchase |
2023-01-25 4:35 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) |
View |
| 2023-01-23 Purchase |
2023-01-25 4:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) |
View |
| 2023-01-23 Purchase |
2023-01-25 4:26 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
9,900 | $4.9994 | $49,494 | 21,797,510 (Indirect Direct) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:25 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:22 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:19 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:16 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
38,139 | $4.9976 | $190,603 | 21,787,610 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 4:06 pm |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
85,082 | $5.1516 | $438,308 | 908,893 (Direct) |
View |
| 2023-01-12 Purchase |
2023-01-17 4:36 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) |
View |
| 2023-01-12 Purchase |
2023-01-17 4:34 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) |
View |
| 2023-01-12 Purchase |
2023-01-17 4:32 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) |
View |
| 2023-01-12 Purchase |
2023-01-17 4:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
5,378 | $4.9466 | $26,603 | 21,749,471 (Indirect Direct) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:40 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:37 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:35 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:32 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
309,070 | $4.7865 | $1,479,359 | 21,744,093 (Indirect Direct) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:29 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:28 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:24 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
300 | $4.9767 | $1,493 | 21,435,023 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:21 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:17 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:14 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:11 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
40,327 | $4.9988 | $201,588 | 21,434,723 (Indirect Direct) |
View |
| 2022-11-03 Purchase |
2022-11-07 4:30 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) |
View |
| 2022-11-03 Purchase |
2022-11-07 4:20 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) |
View |
| 2022-11-03 Purchase |
2022-11-07 4:17 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) |
View |
| 2022-11-03 Purchase |
2022-11-07 4:16 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
139,148 | $4.9187 | $684,427 | 21,394,396 (Indirect Direct) |
View |
| 2022-10-27 Purchase |
2022-10-31 5:20 pm |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
76,877 | $4.8602 | $373,638 | 21,255,248 (Indirect Direct) |
View |
| 2022-10-27 Purchase |
2022-10-31 5:20 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) |
View |
| 2022-10-27 Purchase |
2022-10-31 5:19 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) |
View |
| 2022-10-27 Purchase |
2022-10-31 5:17 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Svennilson Peter Kutzkey Tim Ponoi Capital II LP Ponoi II Management LLC PONOI CAPITAL LP Ponoi Management LLC COLUMN GROUP II LP Column Group Management LP Column Group II GP LP Director 10% Owner |
76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) |
View |
| 2022-10-25 Purchase |
2022-10-27 6:58 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) |
View |
| 2022-10-25 Purchase |
2022-10-27 6:55 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner |
123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-17 Exercise |
2023-01-18 4:06 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
85,082 | $1.44 | 908,893 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-18 4:06 pm |
N/A 2023-01-23 |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
85,082 | $0 | 908,893 (Direct) |
View |
| 2022-11-04 Option Award |
2022-11-08 9:07 pm |
N/A 2032-11-03 |
NGM BIOPHARMACEUTICALS INC | NGM | Lieu Hsiao D SVP, Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |